Bellicum Pharmaceuticals Inc

NASDAQ:BLCM   3:41:54 PM EDT
2.99
-0.15 (-4.78%)
Earnings Announcements

Bellicum Reports Fourth Quarter 2020 Financial Results And Provides Operational Update

Published: 03/30/2021 20:20 GMT
Bellicum Pharmaceuticals Inc (BLCM) - Bellicum Reports Fourth Quarter 2020 Financial Results and Provides Operational Update.
Bellicum Pharmaceuticals Inc - Expects Current Cash Resources Will Be Sufficient to Meet Operating Requirements Into Q2 of 2022.
Revenue is expected to be $0.3 Million
Adjusted EPS is expected to be -$1.37

Next Quarter Revenue Guidance is expected to be $0.3 Million
Next Quarter EPS Guidance is expected to be -$1.37

More details on our Analysts Page.